FDA seeks input on transparency with industry
This article was originally published in The Silver Sheet
Executive Summary
FDA is collecting information on ways to improve transparency with regulated industries - the third phase of its ongoing transparency initiative ("The Silver Sheet" December 2009). The agency is seeking public comment through April 12 on issues raised during listening sessions with industry in January. FDA is also gathering advice on how it can improve regulatory training and education for industry, guidance development, channels of communication with industry, and the timeliness and usefulness of its answers to industry questions